Recent Updates
Recently added Catalysts
KURA Positive Sentiment Score: 70/100

Kura Oncology to Report First Quarter 2025 Financial Results

Thursday, April 24, 2025 1 min read
Key Takeaway: Kura Oncology, a clinical-stage biopharmaceutical company, has announced that it will report its first quarter 2025 financial results on May 1, 2025, after U.S. market close. Management will follow the announcement with a conference call and webcast at 4:30 p.m. ET to discuss the results and provide an update on corporate activities. Details on accessing the call and the company's investor relations can be found on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is committed to precision medicines for cancer treatment.
  • The upcoming financial results could indicate positive growth for the company.
  • A corporate update will be provided, potentially revealing new developments.

Full Press Release Details

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report first quarter 2025 financial results after the close of U.S. financial markets on Thursday, May 1, 2025. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the financial results and provide a corporate update.
The live call may be accessed by dialing (800) 245-3047 for domestic callers and (203) 518-9765 for international callers and entering the conference ID: KURAQ1. A live webcast and archived replay of the event will be available here or online from the investor relations section of the company website at www.kuraoncology.com.
patti.bank@icrhealthcare.com
Alexandra Weingarten
Associate Director, Corporate Communications
& Investor Relations
alexandra@kuraoncology.com

Frequently Asked Questions

When will Kura Oncology announce Q1 2025 financial results?

Kura Oncology will report its Q1 2025 financial results on May 1, 2025.

What time is the Kura Oncology conference call?

The conference call is scheduled for 4:30 p.m. ET on May 1, 2025.

How can I access the Kura Oncology conference call?

Dial (800) 245-3047 for domestic or (203) 518-9765 for international access.

Where can I find the webcast of the Kura Oncology event?

The webcast will be available on Kura's investor relations webpage.

Who should I contact for more information about Kura Oncology?

For inquiries, contact Alexandra Weingarten at alexandra@kuraoncology.com.

Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology Q1 2025 financial results cancer treatment biopharmaceutical
Last updated: Apr 24, 2025